He-San Luo

643 total citations
24 papers, 450 citations indexed

About

He-San Luo is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, He-San Luo has authored 24 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 11 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in He-San Luo's work include Esophageal Cancer Research and Treatment (10 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Esophageal and GI Pathology (5 papers). He-San Luo is often cited by papers focused on Esophageal Cancer Research and Treatment (10 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Esophageal and GI Pathology (5 papers). He-San Luo collaborates with scholars based in China, United States and Russia. He-San Luo's co-authors include Dehua Wu, Zhong‐Yi Dong, Li Liu, Qin Zeng, He-Cheng Huang, Sheng‐Xi Wu, Ze-Sen Du, Chuanhui Cao, Qiang Fu and Yi‐Long Wu and has published in prestigious journals such as Scientific Reports, Biochemical Journal and The Annals of Thoracic Surgery.

In The Last Decade

He-San Luo

20 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
He-San Luo China 12 194 162 158 151 115 24 450
Lan-Jun Zhang China 13 177 0.9× 238 1.5× 169 1.1× 277 1.8× 91 0.8× 23 549
Fabiana Napolitano Italy 12 144 0.7× 104 0.6× 220 1.4× 172 1.1× 94 0.8× 31 448
Priyamal Silva United Kingdom 6 233 1.2× 112 0.7× 162 1.0× 78 0.5× 225 2.0× 10 453
Shengming Jin China 13 290 1.5× 84 0.5× 74 0.5× 165 1.1× 210 1.8× 32 481
Julien Dagher France 12 216 1.1× 65 0.4× 179 1.1× 375 2.5× 125 1.1× 23 509
Masashi Mikubo Japan 12 119 0.6× 63 0.4× 213 1.3× 256 1.7× 96 0.8× 40 458
Silvia de Muga Spain 12 264 1.4× 124 0.8× 112 0.7× 201 1.3× 149 1.3× 15 479
Aafke Creemers Netherlands 11 77 0.4× 125 0.8× 215 1.4× 140 0.9× 121 1.1× 16 353
Ingirídur Skírnisdóttir Sweden 16 176 0.9× 77 0.5× 234 1.5× 77 0.5× 107 0.9× 26 682
Matthew R. Strickland United States 8 251 1.3× 57 0.4× 218 1.4× 150 1.0× 74 0.6× 18 475

Countries citing papers authored by He-San Luo

Since Specialization
Citations

This map shows the geographic impact of He-San Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He-San Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He-San Luo more than expected).

Fields of papers citing papers by He-San Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by He-San Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He-San Luo. The network helps show where He-San Luo may publish in the future.

Co-authorship network of co-authors of He-San Luo

This figure shows the co-authorship network connecting the top 25 collaborators of He-San Luo. A scholar is included among the top collaborators of He-San Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with He-San Luo. He-San Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Wei, Wei, Jian Wang, He-San Luo, et al.. (2024). HLA diversity unveils susceptibility and organ-specific occurrence of second primary cancers: a prospective cohort study. BMC Medicine. 22(1). 443–443.
4.
Luo, He-San, Yung‐Ming Chen, Weizhen Huang, et al.. (2021). Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer. Radiation Oncology. 16(1). 201–201. 26 indexed citations
5.
6.
7.
Bai, Xue, Dehua Wu, Si-Cong Ma, et al.. (2020). Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study. Journal for ImmunoTherapy of Cancer. 8(1). e000381–e000381. 45 indexed citations
8.
Luo, He-San & Dehua Wu. (2019). Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis. Pathology - Research and Practice. 215(3). 512–518. 11 indexed citations
9.
10.
Wang, Xiaojian, et al.. (2019). First-Line Checkpoint Inhibitors for Wild-Type Advanced Non-Small-Cell Cancer: A Pair-Wise And Network Meta-Analysis. Immunotherapy. 11(4). 311–320. 7 indexed citations
11.
12.
Du, Ze-Sen, et al.. (2018). Preoperative Administration of Olive Oil Reduces Chylothorax After Minimally Invasive Esophagectomy. The Annals of Thoracic Surgery. 107(5). 1540–1543. 21 indexed citations
13.
14.
15.
Luo, He-San, et al.. (2017). Meta-analysis of survival benefit with postoperative chemoradiotherapy in patients of lymph node positive esophageal carcinoma. Clinical & Translational Oncology. 20(7). 889–898. 12 indexed citations
16.
Wu, Sheng‐Xi, et al.. (2017). Effect of consolidation chemotherapy following definitive chemoradiotherapy in patients with esophageal squamous cell cancer. Scientific Reports. 7(1). 16870–16870. 13 indexed citations
17.
Dong, Zhong‐Yi, Qin Zeng, He-San Luo, et al.. (2012). Increased expression of OCT4 is associated with low differentiation and tumor recurrence in human hepatocellular carcinoma. Pathology - Research and Practice. 208(9). 527–533. 22 indexed citations
18.
Luo, He-San, et al.. (2011). Down‐regulation of RhoE is associated with progression and poor prognosis in hepatocellular carcinoma. Journal of Surgical Oncology. 105(7). 699–704. 19 indexed citations
19.
Luo, He-San, et al.. (2011). Protein kinase CK2α is overexpressed in colorectal cancer and modulates cell proliferation and invasion via regulating EMT-related genes. Journal of Translational Medicine. 9(1). 97–97. 93 indexed citations
20.
Liu, Li, et al.. (2009). [Effect of protein kinase CK2 gene silencing on radiosensitization in human nasopharyngeal carcinoma cells].. PubMed. 29(8). 1551–3. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lan-Jun Zhang Breakdown of academic impact, for papers by Fabiana Napolitano Breakdown of academic impact, for papers by Priyamal Silva Breakdown of academic impact, for papers by Shengming Jin Breakdown of academic impact, for papers by Julien Dagher Breakdown of academic impact, for papers by Masashi Mikubo Breakdown of academic impact, for papers by Silvia de Muga Breakdown of academic impact, for papers by Aafke Creemers Breakdown of academic impact, for papers by Ingirídur Skírnisdóttir Breakdown of academic impact, for papers by Matthew R. Strickland
Rankless by CCL
2026